Elizabeth Prodromou
About Elizabeth Prodromou
Elizabeth Prodromou is the Managing Director for Greece at Bristol-Myers Squibb, based in Athens. She has extensive experience in regulatory affairs and market access, and holds a Bachelor's degree in Chemistry from the National & Kapodistrian University of Athens.
Company
Elizabeth Prodromou is currently the Managing Director, Greece at Bristol-Myers Squibb, a globally recognized biopharmaceutical company. She is also serving as the Business Unit Director for Oncology within the same organization in Greece. Her leadership in these roles underscores her significant contributions to the company’s operations and strategic initiatives in Greece.
Title
Elizabeth Prodromou holds the title of Managing Director, Greece at Bristol-Myers Squibb. In addition to her role as Managing Director, she also serves as the Business Unit Director for Oncology in Greece.
Education and Expertise
Elizabeth Prodromou has an extensive educational background. She completed a Bachelor's degree in Chemistry at the National & Kapodistrian University of Athens in 1993. She furthered her executive education with a General Management Program at CEDEP - Executive Development in 2017 and a Strategic Leadership Program at Columbia Business School in 2018. These programs have equipped her with robust strategic leadership and general management skills that contribute to her effective leadership at Bristol-Myers Squibb.
Background
Elizabeth Prodromou has a well-rounded background in the pharmaceutical and healthcare sectors. She served as Market Access Director at Bristol-Myers Squibb from 2011 to 2014 and as Director of Regulatory Affairs from 2008 to 2011. Prior to that, she was the Regulatory Affairs Manager at Abbott from 2003 to 2008. This extensive experience in various regulatory and market access roles has provided her with a comprehensive understanding of the pharmaceutical industry in Greece.
Achievements
Elizabeth Prodromou has been leading the Greece operations at Bristol-Myers Squibb since June 2017, demonstrating her capacity for strategic leadership and operational excellence. Her tenure has included roles such as Market Access Director, emphasizing her expertise in navigating the complexities of market regulations. Her background in regulatory affairs, particularly her time as Director of Regulatory Affairs and Regulatory Affairs Manager, highlights her proficiency in ensuring compliance and advocating for patient access to innovative treatments.